Evidence map›Paper›PMID 38497356›Full record

ArticleGlia2024

ER-stress response in retinal Müller glia occurs significantly earlier than amyloid pathology in the Alzheimer's mouse brain and retina.

Sarah I Palko, Marc R Benoit, Annie Y Yao, Royce Mohan, Riqiang Yan

Open access · bronzeAbstract read
In one paragraph

Article in Glia, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
2.3field-weighted citation impact, top 12% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 10 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Review
  7. Diabetic retinopathy and Alzheimer's disease: Convergence of the unfolded protein response in neurodegeneration.Alzheimer's & dementia : the journal of the Alzheimer's Association · 2025
    Review
  8. Review
  9. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 1 institution in 1 country.

Sarah I PalkoDepartment of Neuroscience, University of Connecticut Health Center, Farmington, Connecticut, USA.ORCID 0000-0003-3862-8488
Marc R BenoitDepartment of Neuroscience, University of Connecticut Health Center, Farmington, Connecticut, USA.
Annie Y YaoDepartment of Neuroscience, University of Connecticut Health Center, Farmington, Connecticut, USA.
Royce MohanDepartment of Neuroscience, University of Connecticut Health Center, Farmington, Connecticut, USA.
Riqiang YanDepartment of Neuroscience, University of Connecticut Health Center, Farmington, Connecticut, USA.ORCID 0000-0001-7195-7617
UConn Health · US

Funding

Roles of reticulon proteins in neurodegenerative disordersR01AG025493 · NIA · UNIVERSITY OF CONNECTICUT SCH OF MED/DNT · PI YAN, RIQIANG · 2005 to 2024
$5.9M
Supplement for BACE1 in neurodegeneration and neuronal dysfunctionR01NS074256 · NINDS · UNIVERSITY OF CONNECTICUT SCH OF MED/DNT · PI RIQIANG YAN · 2011 to 2026
$5.8M
Role of the CX3CL1 C-terminus in reversing age-dependent Alzheimers neurodegenerationRF1AG058261 · NIA · UNIVERSITY OF CONNECTICUT SCH OF MED/DNT · PI YAN, RIQIANG · 2017 to 2023
$5.0M
Inhibition of BACE1 for benefiting Alzheimer's patientsR01AG046929 · NIA · UNIVERSITY OF CONNECTICUT SCH OF MED/DNT · PI RIQIANG YAN · 2013 to 2026
$3.9M
Inhibition of BACE1 for benefiting Alzheimer's patientsRF1AG046929 · NIA · UNIVERSITY OF CONNECTICUT SCH OF MED/DNT · PI YAN, RIQIANG · 2018 to 2018
$3.3M
Roles of reticulon proteins in neurodegenerative disordersRF1AG025493 · NIA · UNIVERSITY OF CONNECTICUT SCH OF MED/DNT · PI YAN, RIQIANG · 2020 to 2020
$3.0M
BACE1 in neurodegeneration and neurological dysfunctionRF1NS074256 · NINDS · UNIVERSITY OF CONNECTICUT SCH OF MED/DNT · PI YAN, RIQIANG · 2021 to 2021
$2.1M
PAD4 in Retinal GliosisR21EY028699 · NEI · UNIVERSITY OF CONNECTICUT SCH OF MED/DNT · PI MOHAN, ROYCE · 2018 to 2019
$636k
The role of beta-secretase 1 (BACE1) in modulating excitatory synaptic and circuit function and behaviorF30AG081134 · NIA · UNIVERSITY OF CONNECTICUT SCH OF MED/DNT · PI YAO, ANNIE Y · 2023 to 2025
$125k
NEI NIH HHS R21 EY028699NIA NIH HHS AG025493NIA NIH HHS F30 AG081134NIA NIH HHS R01 AG025493NIA NIH HHS R01 AG046929NIA NIH HHS RF1 AG025493NIA NIH HHS RF1 AG046929NIA NIH HHS RF1 AG058261NIH HHS AG046929NIH HHS RF1AG058261NINDS NIH HHS NS074256NINDS NIH HHS R01 NS074256NINDS NIH HHS RF1 NS074256
6 · The paper itself

Abstract

Alzheimer's Disease (AD) pathogenesis is thought to begin up to 20 years before cognitive symptoms appear, suggesting the need for more sensitive diagnostic biomarkers of AD. In this report, we demonstrated pathological changes in retinal Müller glia significantly earlier than amyloid pathology in AD mouse models. By utilizing the knock-in NLGF mouse model, we surprisingly discovered an increase in reticulon 3 (RTN3) protein levels in the NLGF retina as early as postnatal day 30 (P30). Despite RTN3 being a canonically neuronal protein, this increase was noted in the retinal Müller glia, confirmed by immunohistochemical characterization. Further unbiased transcriptomic assays of the P30 NLGF retina revealed that retinal Müller glia were the most sensitive responding cells in this mouse retina, compared with other cell types including photoreceptor cells and ganglion neurons. Pathway analyses of differentially expressed genes in glia cells showed activation of ER stress response via the upregulation of unfolded protein response (UPR) proteins such as ATF4 and CHOP. Early elevation of RTN3 in response to challenges by toxic Aβ likely facilitated UPR. Altogether, these findings suggest that Müller glia act as a sentinel for AD pathology in the retina and should aid for both intervention and diagnosis.

Indexed as

Alzheimer DiseaseAmyloidogenic ProteinsAnimalsBrainDisease Models, AnimalEpendymoglial CellsMiceNeurogliaNeuronsRetinaAmyloidogenic ProteinsAlzheimer's retinaER stress responseMüller gliaRTN3transcriptomicunfolded protein response

Identifiers

PMID38497356
PMCPMC11006574
OpenAlexW4392914936

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.